Abstract:Objective: Lingzhihuang capsule (LZHC) is a natural product that consists of 10 commonly used medicinal plants, and it is used in traditional Chinese medicine to promote people's overall health. Previously, LZHC was successfully used as adjuvant therapy for treating patients with cancer. However, the chemical constituents of LZHC and their potential biological functions remain unclear. The aim of this study is to investigate the major bioactive compounds in LZHC and predict their pharmacological targets.Methods: The LZHC constituents were putatively identified by ultra-high performance liquid chromatography coupled with time-of-flight mass spectrometry combined with mass spectrometry-based molecular networking. The targets were predicted using SwissTargetPrediction software, and the associated gene ontology and Kyoto encyclopedia of genes and genomes pathways were analyzed using the Database for Annotation, Visualization, and Integrated Discovery. The mass spectrometry-based molecular network and compound-target-pathway network were constructed using Cytoscape 3.8.0 software.Results: We putatively identified 94 compounds of LZHC by mass spectrometry-based molecular networking, including triterpene (the main structural type) and other clusters (ie, flavonoids and organic acids). Our results suggested that multiple pivotal targets were regulated by LZHC, including tumor necrosis factor, nitric oxide synthase 2, glucocorticoid receptor, estrogen receptor, 3-oxo-5-alpha-steroid 4-dehydrogenase 2, prostaglandin e2 receptor ep4 subtype, estrogen receptor beta, phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, mitogen-activated protein kinase 3, and rac-alpha serine, which are related to signal transduction, positive regulation of transcription from RNA polymerase II promoters, oxidation-reduction processes, inflammatory responses, and other biological processes. Functional annotation of those targets suggested that several signaling pathways may be regulated by LZHC, such as cancer-related proteoglycans, the PI3K-Akt-signaling pathway, and the cAMP-signaling pathway.Conclusions: Our findings reveal the chemical constituents of LZHC and provided scientific support for the efficacy of LZHC in terms of immune regulation, anti-aging, and tumor suppression.

Characterization and Quantitative Analysis of Phenolic Derivatives in Longxuetongluo Capsule by HPLC-DAD-IT-TOF-MS.

Method Development and Application for Multi-Component Quantification in Rats after Oral Administration of Longxuetongluo Capsule by UHPLC–MS/MS

[Research on in Vivo Metabolites of Longxue Tongluo Capsules by Liquid Chromatography Coupled with Hybrid Ion Trap/time-of-flight Mass Spectrometry].

Characterization of the Chemical Constituents in Da-Huang-Gan-Cao-Tang by Liquid Chromatography Coupled with Quadrupole Time-Of-Flight Tandem Mass Spectrometry and Liquid Chromatography Coupled with Ion Trap Mass Spectrometry

Comprehensive Profiling of Lingzhihuang Capsule by Liquid Chromatography Coupled with Mass Spectrometry-Based Molecular Networking and Target Prediction

Characterization of the chemical constituents in Hongjingtian injection by liquid chromatography quadrupole time-of-flight mass spectrometry.

Benefit Clarification of Longxuetongluo Capsule Towards Ischemic Stroke Rats by ischemic stroke rats by LC MS/MS Based Metabolomics

Characterization of Chemical Profile and Quantification of Representative Components of DanLou Tablet, a Traditional Chinese Medicine Prescription, by UHPLC-Q/TOF-MS Combined with UHPLC-TQ-MS.

Neuroprotective Effects of Longxuetongluo Capsule on Ischemic Stroke Rats Revealed by LC-MS/MS-Based Metabolomics Approach

[Identification of Active Components in Longxue Tongluo Capsules Against Ischemic Brain Injury Based on Component-Activity Relationship].

Qualitative and quantitative analysis of multiple components for quality control of Deng-Zhan-Sheng-Mai capsules by ultra high performance liquid chromatography tandem mass spectrometry method coupled with chemometrics.

Rapid identification and analysis of the active components of traditional Chinese medicine Xiaoxuming decoction for ischemic stroke treatment by integrating UPLC-Q-TOF/MS and RRLC-QTRAP MSn method

Qualitative and quantitative analysis of multiple components for quality control of Deng-Zhan-Sheng-Mai capsules by UHPLC – MS / MS coupled with chemometrics

Neuroprotective Effects of Longxue Tongluo Capsule on Ischemic Stroke Rats Revealed by LC-MS/MS-based Metabolomics Approach

Pharmacokinetics of the Material Basis Compounds of Tianshu Capsule in Treating Migraine

TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome

Comprehensive identification of 125 multifarious constituents in Shuang–huang–lian powder injection by HPLC-DAD-ESI-IT-TOF-MS

A systematic UHPLC-Q-TOF-MS/MS-based strategy for analysis of chemical constituents and related in vivo metabolites of Buyang Huanwu decoction

Chemical profiling and antioxidant evaluation of Yangxinshi Tablet by HPLC-ESI-Q-TOF-MS/MS combined with DPPH assay

Characterization of Constituents in Longxue Tongluo Capsules by RRLC-Q-TOF MS

Development of a Non-Target Screening and Quantitative Analysis Strategy Based on UPLC-Q-TOF/MS and UPLC-QQQ/MS to Improve the Quality Control of Wuling Capsule